Perimeter Medical Imaging AI (TSXV:PINK) Stock Valuation, Peer Comparison & Price Targets

Share Price vs Fair Value

What is the Fair Price of PINK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate PINK's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate PINK's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PINK?

Key metric: As PINK barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for PINK. This is calculated by dividing PINK's market cap by their current book value.
What is PINK's PB Ratio?
PB Ratio	3.4x
Book	US$12.80m
Market Cap	US$40.07m

PINK key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	43.2x
Enterprise Value/EBITDA	-1.7x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does PINK's PB Ratio compare to its peers?

The above table shows the PB ratio for PINK vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	14.1x
NSCI Nanalysis Scientific	1.7x	n/a	CA$43.0m
ASG Aurora Spine	5x	n/a	CA$33.3m
TLT Theralase Technologies	42.6x	71.9%	CA$68.1m
THRM Therma Bright	7.3x	n/a	CA$11.1m
PINK Perimeter Medical Imaging AI	3.4x	-10.2%	CA$56.0m

Price-To-Book vs Peers: PINK is good value based on its Price-To-Book Ratio (3.4x) compared to the peer average (14.1x).

Price to Book Ratio vs Industry

How does PINK's PB Ratio compare vs other companies in the CA Medical Equipment Industry?

2 Companies	Price / Book	Estimated Growth	Market Cap
SCYB Scryb	0.4x	n/a	US$3.44m
ASEP ASEP Medical Holdings	0.3x	n/a	US$3.02m

No more companies available in this PB range

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: PINK is expensive based on its Price-To-Book Ratio (3.4x) compared to the North American Medical Equipment industry average (2.5x).

Price to Book Ratio vs Fair Ratio

What is PINK's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PINK PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	3.4x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate PINK's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PINK forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	CA$0.66	CA$3.25 +392.4%	76.1%	CA$6.75	CA$1.50	n/a	3
Nov ’25	CA$0.46	CA$4.13 +796.7%	63.6%	CA$6.75	CA$1.50	n/a	2
Oct ’25	CA$0.56	CA$3.08 +450.6%	84.3%	CA$6.75	CA$1.00	n/a	3
Sep ’25	CA$0.31	CA$3.08 +894.6%	84.3%	CA$6.75	CA$1.00	n/a	3
Aug ’25	CA$0.48	CA$3.08 +542.4%	84.3%	CA$6.75	CA$1.00	n/a	3
Jul ’25	CA$0.37	CA$3.08 +733.3%	84.3%	CA$6.75	CA$1.00	n/a	3
Jun ’25	CA$0.53	CA$3.88 +631.1%	74.2%	CA$6.75	CA$1.00	n/a	2
May ’25	CA$0.52	CA$3.88 +645.2%	74.2%	CA$6.75	CA$1.00	n/a	2
Apr ’25	CA$0.87	CA$4.38 +402.9%	54.3%	CA$6.75	CA$2.00	n/a	2
Mar ’25	CA$0.98	CA$3.75 +282.7%	56.8%	CA$6.75	CA$2.00	n/a	3
Feb ’25	CA$1.01	CA$3.75 +271.3%	56.8%	CA$6.75	CA$2.00	n/a	3
Jan ’25	CA$1.22	CA$3.75 +207.4%	56.8%	CA$6.75	CA$2.00	n/a	3
Dec ’24	CA$0.86	CA$3.75 +336.0%	56.8%	CA$6.75	CA$2.00	n/a	3
Nov ’24	CA$0.90	CA$3.75 +316.7%	56.8%	CA$6.75	CA$2.00	CA$0.46	3
Oct ’24	CA$1.20	CA$3.75 +212.5%	56.8%	CA$6.75	CA$2.00	CA$0.56	3
Sep ’24	CA$1.45	CA$3.75 +158.6%	56.8%	CA$6.75	CA$2.00	CA$0.31	3
Aug ’24	CA$1.65	CA$3.56 +115.9%	52.6%	CA$6.75	CA$2.00	CA$0.48	4
Jul ’24	CA$1.79	CA$3.56 +99.0%	52.6%	CA$6.75	CA$2.00	CA$0.37	4
Jun ’24	CA$1.73	CA$3.56 +105.9%	52.6%	CA$6.75	CA$2.00	CA$0.53	4
May ’24	CA$1.92	CA$3.56 +85.5%	52.6%	CA$6.75	CA$2.00	CA$0.52	4
Apr ’24	CA$1.60	CA$4.06 +153.9%	42.3%	CA$6.75	CA$2.00	CA$0.87	4
Mar ’24	CA$1.65	CA$4.06 +146.2%	42.3%	CA$6.75	CA$2.00	CA$0.98	4
Feb ’24	CA$1.70	CA$4.06 +139.0%	42.3%	CA$6.75	CA$2.00	CA$1.01	4
Jan ’24	CA$1.64	CA$4.06 +147.7%	42.3%	CA$6.75	CA$2.00	CA$1.22	4
Dec ’23	CA$1.37	CA$4.06 +196.5%	42.3%	CA$6.75	CA$2.00	CA$0.86	4
Nov ’23	CA$1.40	CA$5.49 +292.0%	18.6%	CA$6.75	CA$4.00	CA$0.90	4

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

NeuPath Health

CA$9.0m

Provides chronic pain management services in Canada.

NPTH

CA$0.17

7D

6.3%

1Y

9.7%

Medical Facilities

CA$369.6m

Through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States.

DR

CA$15.55

7D

3.2%

1Y

79.1%

Carebook Technologies

CA$6.2m

Engages in the development and commercialization of digital health platforms for assessments, reporting, and targeted solutions in Canada, the United States, Europe, Latin America, Asia, and internationally.

CRBK

CA$0.05

7D

-37.5%

1Y

-28.6%

Perimeter Medical Imaging AI Valuation